COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Announcement on Resolutions of the 16th Meeting of the Fifth Board of Directors of Jilin Zixin Pharmaceutical Co., Ltd.

Page view

Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2014-037

Jilin Zixin Pharmaceutical Co., Ltd.

Announcement on Resolutions of the 16th Meeting of the 5th Board of Directors

The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.

The 16th meeting of the 5th Board of Directors of Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as the “Company”) was held on July 22, 2014 by way of on-site voting. The meeting was notified by telephone, electronic on July 12, 2014. By mail, etc., the meeting should be attended by 7 directors and 7 actual attendees. The meeting was held in compliance with the relevant provisions of the Company Law and the Articles of Association. The convening procedures and voting results of this meeting are legal and valid.

After careful consideration by the attending directors, the following proposals were passed:

I. The resolution of the full text and summary of the 2014 Semi-annual Report was reviewed and approved.

Review results: 7 votes in favor, 0 votes against, 0 abstentions

The company's "2014 Semi-annual Report" is available on the website of www.cninfo.com.cn. The company's 2014 Semi-annual Report Summary is detailed in the company's designated information disclosure media and http://www.cninfo.com.cn ://www.cninfo.com.cn).

2. The proposal of reviewing and approving the "Special Report on the Deposit and Actual Use of Funds Raised in the Semi-annual 2014"

Review results: 7 votes in favor, 0 votes against, 0 abstentions

The full report is published in the company's designated information disclosure media and Juchao Information Network (http://www.cninfo.com.cn).

III. The resolution of the "Special Work Plan for Regulating the Behavior of Controlling Shareholders and Actual Controllers of Listed Companies" was considered and approved.

Review results: 7 votes in favor, 0 votes against, 0 abstentions

According to the “Notice on Launching the Special Work on Preventing the Behavior of Controlling Shareholders and Actual Controllers of Listed Companies” issued by Jilin Regulatory Bureau of China Securities Regulatory Commission (Ji Zheng Jian Fa [2014] No. 43), the company has formulated relevant plans. For details, please refer to the “Announcement on Preventing the Establishment and Improvement of the Interest Mechanism of the Controlling Shareholders and Actual Controllers Encroaching on Listed Companies” disclosed by the company in the designated information disclosure media and http://www.cninfo.com.cn. (2014-040), "Special Work Plan for Regulating the Behavior of Controlling Shareholders and Actual Controllers of Listed Companies".

4. The resolution of the "Proposal on Safeguarding the Legal Rights and Interests of Small and Medium-sized Investors" was considered and approved.

Review results: 7 votes in favor, 0 votes against, 0 abstentions

According to the Notice of the Jilin Regulatory Commission of Jilin Regulatory Commission on the "Special Work for Safeguarding the Legal Rights and Interests of Small and Medium-sized Investors" and the "Notice on Further Doing a Good Job of Cash Dividing", according to the notification requirements, the company formulated 2014 protection according to its actual situation. Small and medium investor rights work plan. For details, please refer to the company's designated information disclosure media and http://www.cninfo.com.cn (the program on safeguarding the legitimate rights and interests of small and medium investors).

V. The “Special Explanation on the Elimination of the Impact of Matters Retained in the 2013 Annual Audit Report” was reviewed and approved.

Review results: 7 votes in favor, 0 votes against, 0 abstentions

For details of the impact of the Board of Directors on the elimination of the issues involved in the 2013 audit report, please refer to the company's designated information disclosure media and http://www.cninfo.com.cn Special note on the impact of matters related to the reservation in the audit report

Special announcement

Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors

July 23, 2014